Global Generic Drugs Market

$2,950.00

产品代码: GH04158R 行业: 地区:

Generic drugs are medications that have the same active ingredients as brand-name drugs but are sold under a different name. They are manufactured and sold after the patent for the brand-name drug has expired, allowing other companies to produce and sell the same medication at a lower cost. Generic drugs are regulated by the FDA (Food and Drug Administration) and must meet the same quality and safety standards as brand-name drugs. They have the same dosage form, 力量, and route of administration as the brand-name drug, and have been proven to be bioequivalent or very similar in efficacy and safety. The global generic drugs market is anticipated to increase by USD 226.3 十亿直到 2029 年均增长 7.2 根据最新市场估计的百分比.

该报告涵盖了市场规模和增长, 分割, 区域细分, 竞争格局, trends and strategies for global generic drugs market. 它提供了对市场的定量分析,使利益相关者能够利用当前的市场机会. 该报告还根据市场趋势和主要竞争对手的方法确定了最重要的机会和战略细分市场.

该行业报告提供了全球市场的市场估计和预测, followed by a detailed analysis of the route of administration, 应用, 最终用户, 和地区. The global market for generic drugs can be segmented by route of administration: 可注射的, 口服, topical, 其他的. The oral segment was the largest contributor to the global generic drugs market in 2022. Generic drugs market is further segmented by application: anti-cancer drugs, anti-infectives, cardiovascular products, central nervous system (CNS) 药物, drugs for arthritis, respiratory products, 其他的. 据研究, the cardiovascular products segment had the largest share in the global generic drugs market. 基于最终用户, the generic drugs market is segmented into: 医院和诊所, 零售药店, 其他的. The retail pharmacies segment held the largest revenue share in 2022. 根据地区, the generic drugs market also can be divided into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美. 全球范围, Asia-Pacific made up the largest share of the generic drugs market.

市场细分
按给药途径: 可注射的, 口服, topical, 其他的
按申请: anti-cancer drugs, anti-infectives, cardiovascular products, central nervous system (CNS) 药物, drugs for arthritis, respiratory products, 其他的
按最终用户: 医院和诊所, 零售药店, 其他的
按地区: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美

The report also provides analysis of the key companies of the industry and their detailed company profiles including Aspen Pharmacare Holdings Limited, 雅培实验室, 艾伯维公司, Aurobindo Pharma Limited, Baxter International Inc., Cipla Limited, Eli Lilly and Company, Fresenius Kabi AB, 葛兰素史克公司, Hikma Pharmaceuticals plc, Lupin Limited, Mylan N.V., 诺华公司, 辉瑞公司, 赛诺菲公司, STADA Arzneimittel AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, 除其他外. 在这份报告中, 全面分析关键参与者及其策略,以了解市场的竞争前景.
*索取免费样品以获得完整的公司列表

报告范围
• To analyze and forecast the market size of the global generic drugs market.
• To classify and forecast the global generic drugs market based on route of administration, 应用, 最终用户, 地区.
• To identify drivers and challenges for the global generic drugs market.
• 检查竞争性发展,例如合并 & 收购, 协议, 合作与伙伴关系, ETC。, in the global generic drugs market.
• To identify and analyze the profile of leading players operating in the global generic drugs market.

为什么选择这份报告
• Gain a reliable outlook of the global generic drugs market forecasts from 2023 到 2029 跨场景.
• 确定投资的增长领域.
• 通过公司简介和市场数据保持领先于竞争对手.
• 以 Excel 格式进行跨场景分析的市场预估.
• 三个月的战略咨询和研究支持.
• 为单用户许可证提供打印验证.

Global Generic Drugs Market

对这份报告感兴趣? 立即获取免费样品!
Global Generic Drugs Market - 报告范围
报告属性

细节

基准年

2022

预测年份

2023-2029

复合年增长率 (2023-2029)

7.2%

页数

90

行业参与者

阿斯彭医药控股有限公司, 雅培实验室, 艾伯维公司, Aurobindo Pharma Limited, Baxter International Inc., Cipla Limited, Eli Lilly and Company, Fresenius Kabi AB, 葛兰素史克公司, Hikma Pharmaceuticals plc, Lupin Limited, Mylan N.V., 诺华公司, 辉瑞公司, 赛诺菲公司, STADA Arzneimittel AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited

相关报道
想要定制此报告?
本报告可以灵活地根据您的具体需求进行定制. 我们的分析师和行业专家团队将直接与您合作,全面了解您的需求.
滚动至顶部

下载免费样品 - Global Generic Drugs Market

请填写我们的表格,我们会尽快回复您.